Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

SHE:002349 Revenue

Jinghua Pharmaceutical Group had revenue of 354.99M CNY in the quarter ending September 30, 2026, a decrease of -1.63%. This brings the company's total for the last twelve months to 1.48B, up 1.95% year-over-year. In the year 2025, Jinghua Pharmaceutical Group had annual revenue of 1.46B with 4.13% growth. That makes Jinghua Pharmaceutical Group the 16,765th largest company in the world by revenue and 3,036th in China.

• Revenue (ttm): 1.48B
• Revenue Growth: +1.95%
• P/S Ratio: 3.91
• Revenue / Employee: 1.01M
• Employees: 1,462
• Market Cap: 5.68B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.28B 87.7%
• International 180.17M 12.3%

Fiscal year ended Dec 31, 2025 See the full SHE:002349 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.46B	57.87M	4.13%
Dec 31, 2024	1.40B	-109.66M	-7.25%
Dec 31, 2023	1.51B	-61.31M	-3.90%
Jan 1, 2023	1.57B	215.19M	15.85%
Jan 1, 2022	1.36B	76.51M	5.97%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error